Angelman Syndrome Foundation Call for Proposals Grant

Angelman Syndrome Foundation Call for Proposals Grant

Status: ACTIVE
Funder: Angelman Syndrome Foundation
Amount: Up to US $100,000
Last Updated: September 19, 2025

Summary

The Angelman Syndrome Foundation is calling for proposals to advance research in Angelman syndrome. With over $15.8 million invested in finding effective treatments and potential cures, priority is given to projects addressing unmet needs in the field. Grants of up to $100,000 are available for one- or two-year terms. Researchers from all countries are encouraged to apply, fostering innovation and collaboration towards improving the quality of life for individuals affected by this condition.

Overview

The Mission The mission of the Angelman Syndrome Foundation is to advance the awareness and treatment of Angelman syndrome through education and information, research, and support for individuals with Angelman syndrome, their families and other concerned parties. We exist to give all of them a reason to smile, with the ultimate goal of finding a cure. ASF Funded Research The Angelman Syndrome Foundation has invested over $15.8 million in Angelman syndrome research to date, supporting projects worldwide in the quest to find treatments for Angelman syndrome and ultimately a cure. Treatments resulting from the ASF’s $15 million investment in research help individuals with Angelman syndrome live better lives today and lead to better lives tomorrow. The Angelman Syndrome Foundation is dedicated to funding the highest caliber of research on Angelman syndrome. It is our hope that these funded researchers, and their collaborators and peers, will bring forth new discoveries that ultimately lead to safe and effective therapies that improve the quality of life for all with Angelman syndrome. Angelman Syndrome Foundation Call for Proposals Current Research Priorities The ASF Scientific Advisory Committee identified the following areas of unmet need in AS research. Priority will be given to the following topics: Projects studying or correcting the heterozygous effect of non-UBE3A genes in deletion. Projects studying the potential results of increasing UBE3A after therapies or for some subtypes of AS. Projects studying delivery of therapies and potential for improvement. Symptomatic therapies that impact the daily life of people with Angelman syndrome and their families. Proposals that do not address these topics are still welcome and will be given full consideration. Funding One- or two-year grants are awarded for various amounts of up to $100,000 per year.

Eligibility

You can learn more about this opportunity by visiting the funder's website. Researchers from all countries are encouraged to apply.